Job title: Chief Technical Officer
Dr Michael West has a PhD in Chemistry from James Cook University, an MIP from University of Technology Sydney and professional management qualifications. Michael has been successful in translating technology challenges in both human and animal health over a 30 year period. Michael joined Exopharm in 2021 and brings an extensive technical, commercial and entrepreneurial background to the management team. Prior to joining Exopharm, Michael was Chief Operating Officer and Head of Research & Development at Anatara Lifesciences (ASX:ANR) where he was instrumental in the development of several animal and human health products, taking four of these from inception to the clinic. Michael has a long association with commercial manufacture lead development and manufacturing teams in the synthesis of fondaparinux sodium (anti-coagulant) and hyaluronan based oncology products (HA-Irinotecan). Michael is an adjunct faculty member at the University of Queensland, School of Biomolecular Sciences.
Continuous Processing Potential Outside of Traditional Small Molecule & Monoclonal Antibody Applications 1:05 pm
• What technologies are available for cell, gene, and vaccine continuous manufacturing? • How close are these technologies to commercialization? – How easy are commercially available technologies able to be adapted to process needs? • What are the drivers for exploring CM for modalities outside of the traditional small molecules & monoclonal antibodies?Read more
day: Stream 2 - Day 2